Navigation Links
iBio, Inc. Receives Notice from NYSE MKT Staff that Company Currently is Below Certain Continued Listing Standards
Date:11/23/2012

NEWARK, Del., Nov. 23, 2012 /PRNewswire/ -- iBio, Inc. (NYSE MKT: IBIO) announced that the Company today received notice from NYSE MKT (the "Exchange") Staff that the Company currently is below certain of the Exchange's continued listing standards. The Exchange Staff indicated that its review of the Company's Form 10-Q for the period ended September 30, 2012, indicates that the Company is not in compliance with Section 1003(a)(ii) which applies if a listed company has stockholders' equity of less than $6,000,000 and net losses in its five most recent fiscal years.

(Logo: http://photos.prnewswire.com/prnh/20120419/NY91086LOGO )

The Company is afforded the opportunity to submit a plan of compliance to the Exchange by December 21, 2012, that addresses how the Company intends to regain compliance with Section 1003(a)(ii) of the Company Guide by October 14, 2013. If the Company does not submit a plan of compliance, or if the plan is not accepted by the Exchange, the Company will be subject to delisting procedures as set forth in Section 1010 and Part 12 of the Company Guide.

The Company believes it can provide the Exchange with a satisfactory plan by December 21, 2012, to show that it will be able to return to compliance with Section 1003(a)(ii) of the Company Guide by October 14, 2013.

About iBio, Inc.

iBio develops and offers product applications of its iBioLaunch™ and iBioModulator™ platforms, providing collaborators full support for turn-key implementation of its technology for both proprietary and biosimilar products. The iBioLaunch platform is a proprietary, transformative technology for development and production of biologics using transient gene expression in unmodified green plants. Advantages over other systems include: success with proteins difficult or impossible to produce with other methods; broadly applicable to biologics, including monocl
'/>"/>

SOURCE iBio, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. iBio, Inc. Submits Plan to Satisfy NYSE Amex Continued Listing Standards
2. iBio, Inc. Prices $10 Million Public Offering
3. iBio, Inc. and GE Healthcare form new global alliance
4. UCSB professor receives award for graphene electronics research
5. Watsons Generic Yaz(R) Receives FDA Approval
6. Quanterix Receives Funding From the Department of Homeland Security to Develop Test for Botulinum Toxin
7. Life Technologies Ion Personal Genome Machine Receives San Diegos CONNECT Most Innovative New Product Award
8. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
9. Intimate Bridge 2 Conception, Inc. Receives $4.3M
10. Pacific Meso Center Receives Generous Donation to First Free-Standing Mesothelioma Research Laboratory in Los Angeles
11. BioNeutral Group Receives $400,000 in Equity Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Calif. , May 23, 2013  Saddleback Memorial ... recently became the first hospital on the West ... technology. This new surgical option provides women with a ... Marc Winter , M.D., a ... and surgeon and medical director of minimally invasive surgery ...
(Date:5/23/2013)... , May 23, 2013 BioTrends ... and advisory firms for specialized biopharmaceutical issues, finds ... and infectious disease specialists reported that in the ... (e.g., intentionally delaying treatment) in anticipation of the ... six months ago, when only 6 percent reported ...
(Date:5/23/2013)... Ill. , May 23, 2013 Z ... providing value-added ingredients to a variety of industries, announced ... in a panel discussion at this year,s National Restaurant ... 20-21, 2013, on behalf of the Research Chefs Association.  ... for Restaurants: The Good, the Bad and the Ugly," ...
(Date:5/23/2013)... The New Jersey chapter of the largest organization ... (BDPA), is hosting its 10th annual Families in Technology ... will encourage students and their parents to explore the ... many of the industries’ finest teachers. Held from 9 ... of Technology, the event will include workshops, instruction and ...
Breaking Biology Technology:Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 2Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 3Black Data Processing Associates (BDPA) New Jersey Hosts 10th Annual Families in Technology Day June 8, 2013 2
... Therapeutics, Inc.,(Nasdaq: HALO ), a biopharmaceutical company ... today announced that David,Ramsay, Halozyme,s Vice President and ... in February. Mr. Ramsay will present an,overview of ... milestones at,each conference., -- 10th ...
... Flurizan Will Earn a 23%,Patient Share in the United States, According to ... ... WALTHAM, Mass., Feb. 5 Decision Resources, one of the,world,s leading ... drug,s effect on delaying the progression,from mild cognitive impairment to Alzheimer,s disease ...
... Presenting at BIO CEO & Investor Conference, LOUISVILLE, Colo., ... that it will host a conference call on,Tuesday, February 26, ... year-end earnings. Additionally, Replidyne will present at an upcoming,investor conference ... as follows:, Kenneth J. Collins, President and ...
Cached Biology Technology:Halozyme Therapeutics to Present at the BIO CEO and Investor Conference and the Roth Growth Stock Conference 2Flurizan's Effect in Delaying Progression From Mild Cognitive Impairment to Alzheimer's Disease is Superior to That of Aricept 2Replidyne to Report 2007 Fourth Quarter and Year-End Earnings 2Replidyne to Report 2007 Fourth Quarter and Year-End Earnings 3
(Date:5/24/2013)... the world,s largest and fastest growing open-access publishers, today ... in Physics . , A broad scope journal covering ... an open-science and interactive web platform for the research ... , Frontiers, real-time and interactive peer-review enables fast, ... types. With an average of three months from submission ...
(Date:5/24/2013)... the search for medication against Alzheimer,s disease, scientists have focused ... down Amyloid beta (A-beta). After all, it is the accumulation ... of Alzheimer,s patients. Starting point for the formation of A-beta ... the first to unravel the function of APPL the ... fruit flies. , Alessia Soldano (VIB/KU Leuven): "We have ...
(Date:5/23/2013)... more than 284 million tons of cargo, transit the Panama ... fees for the Panama Canal Authority. Each time a ship ... used from Gatun Lake, which is also a source of ... , However, the advent of very large "super" cargo ... sea, has demanded change. The Panama Canal is being expanded ...
Breaking Biology News(10 mins):Frontiers launches new open-access journal in physics 2Frontiers launches new open-access journal in physics 3A new strategy required in the search for Alzheimer's drugs? 2Reforestation study shows trade-offs between water, carbon and timber 2Reforestation study shows trade-offs between water, carbon and timber 3
... Carolina is a rapidly growing city. Charlotte is also ... a contradiction. , In Charlotte, there are wooded lots ... the towers of the nation,s second largest financial center. ... within the city,s boundaries. Social scientists find the co-existence ...
... It seems the old nature versus nurture debate can,t be ... the Philippines makes a strong case for nurture,s role in ... in the first six months of life predicts earlier puberty ... babies -- an indication that they were not nutritionally stressed ...
... YORK, NY, September 13, 2010) A new study led ... novel molecular pathway underlying Parkinson,s disease and points to existing ... disease. The pathway involved proteins known as polyamines ... in build-up of other toxic proteins in neurons, which causes ...
Cached Biology News:Interdisciplinary research looks at Charlotte's green mystery 2Interdisciplinary research looks at Charlotte's green mystery 3Interdisciplinary research looks at Charlotte's green mystery 4Interdisciplinary research looks at Charlotte's green mystery 5Interdisciplinary research looks at Charlotte's green mystery 6Male maturity shaped by early nutrition 2Male maturity shaped by early nutrition 3New pathway identified in Parkinson's through brain imaging 2New pathway identified in Parkinson's through brain imaging 3New pathway identified in Parkinson's through brain imaging 4
Dnase and Rnase free...
TLN2 Antibody...
Mouse monoclonal [0.N.305] to G protein alpha - BSA and Azide free ( Abpromise for all tested applications). Antigen: Partially purified G protein alpha from rat brain. Entrez GeneID: 2778 ...
Rabbit polyclonal to VEGF Receptor 2 (phospho Y1214) ( Abpromise for all tested applications). entrezGeneID: 3791 SwissProtID: P35968...
Biology Products: